News

Researchers at The Hong Kong Polytechnic University developed two AI models – MMgSN-Net and PGMGVCE – to create virtual contrast-enhanced MRI scans for nasopharyngeal carcinoma using non-contrast images.

In the phase 2 SunRISe-1 trial, TAR-200, a slow-release intravesical device delivering gemcitabine, eliminated tumors in 82% of high-risk NMIBC patients unresponsive to BCG therapy. Nearly half remained cancer-free after 12 months.

Advances in artificial intelligence for porous materials design could impact a wide variety of fields, from orthopedic implants to next-generation batteries.

The team sought to determine whether regions of the eyes and nose had higher temperature outputs, and if they exhibited consistent temperature change.

Researchers have identified a genetic biomarker that predicts whether multiple sclerosis (MS) patients will respond particularly well to treatment with glatiramer acetate. The results come from a multicentre analysis of more than 3,000 MS patients.

Scientists have developed a new diagnostic test that uses just a single drop of blood, costs a couple of dollars and delivers results in only 15 minutes.

The most common whale-dolphin interaction involved dolphins swimming near the whale’s rostrum, akin to bow riding, which could indicate an energy-efficient mode of locomotion and a form of one-sided play by dolphins.

Releasing a newly-identified molecular brake that hinders the ability of T cells to attack tumors could supercharge immunotherapy.

A new study from South Dakota State University reveals how grapevine canes can be converted into plastic-like material that is stronger than traditional plastic and will decompose in the environment in a relatively short amount of time.

Cornell researchers developed machine-learning models that can sift through cell-free RNA and identify key biomarkers for chronic fatigue syndrome.